Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -7.11% | 2.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.11% | 2.88% | |||
| Cost of Revenue | -6.93% | -1.37% | |||
| Gross Profit | -7.56% | 14.56% | |||
| SG&A Expenses | 2.82% | 0.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.57% | -0.95% | |||
| Operating Income | -39.46% | 102.01% | |||
| Income Before Tax | -46.17% | 196.51% | |||
| Income Tax Expenses | -32.61% | 101.52% | |||
| Earnings from Continuing Operations | -50.08% | 243.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 54.93% | 20.83% | |||
| Net Income | -49.65% | 389.60% | |||
| EBIT | -39.46% | 102.01% | |||
| EBITDA | -29.86% | 62.02% | |||
| EPS Basic | -49.89% | 389.48% | |||
| Normalized Basic EPS | -45.44% | 331.46% | |||
| EPS Diluted | -48.60% | 390.57% | |||
| Normalized Diluted EPS | -43.78% | 329.81% | |||
| Average Basic Shares Outstanding | 0.49% | 0.00% | |||
| Average Diluted Shares Outstanding | -2.47% | 0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||